Panagora Asset Management Inc Cti Biopharma Corp Transaction History

Panagora Asset Management Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$0.64 - $0.92 $131 - $189	-206 Closed	0 $0
Q2 2019 Aug 09, 2019	SELL	$0.8 - $1.03 $30,470 - $39,230	-38,088 Reduced 99.46%	206 $0
Q1 2019 May 15, 2019	BUY	$0.9 - $1.37 $34,464 - $52,462	38,294 New	38,294 $37,000
Q1 2018 May 15, 2018	SELL	$2.7 - $4.06 $12,168 - $18,298	-4,507 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$2.47 - $3.34 $11,132 - $15,053	4,507	4,507 $12,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.